Forensic Analyst, Trudence Capital Advisors

Nitin Mangal

Nitin Mangal is a Research Analyst with more than 15 years of experience in Indian equities. He is Pioneer of Corporate Governance and Accounting Research in Indian Market and has successfully developed product for Institutional Investors named as "Analysis Beyond Consensus" during his association with Edelweiss Securities Ltd, Mumbai. Later during the career, he has worked with Veritas Investment Research Corporation, Canada as Asia Consultant covering Indian and US equities. He has been profiled by leading financial newspapers such as Wall Street Journal, Business Standard etc

Forensic Analyst

PB Fintech Ltd- When Zero GST Turns Costly

Trudence Capital Advisors

Trudence Capital Advisors Private Limited is a SEBI-registered Research Analyst, holding SEBI registration number INH000015747. Our firm is dedicated to providing independent and unbiased research on Indian mid to large-cap companies. Trudence Capital is known for its counter-consensus views, with a focus on forensic research and on-ground primary investigations. Our research approach is thorough, involving detailed analysis of accounting practices and governance, alongside extensive channel checks.

Independent & Unbiased Research

Thematic (Sector/Industry)

India Insurance / Thematic (Sector/Industry)

Life Insurance Corporation of India (LICI IN)

<ul>
<li>The passage of the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Bill, 2025 marks a significant regulatory inflection point for the sector and could uplift penetration levels in long-run.</li>
<li>Key reforms include 100% FDI, easing operational constraints, strengthening consumer protection, opening up of <a href="https://www.smartkarma.com/entities/life-insurance-corp-of-india" target="_blank" data-smartkarma-citation="entities:28829:1" rel="noopener">Life Insurance of India (LICI IN)</a> , etc. </li>
<li>Tighter commission regulation and increased competition may pressure intermediary profitability in the near term, posing earnings risk for platforms like <a href="https://www.smartkarma.com/entities/pb-fintech-limited-policybazaar" target="_blank" data-smartkarma-citation="entities:33470:1" rel="noopener">Policybazaar (POLICYBZ IN)</a> (PB Fintech) despite positive long-term sector fundamentals.</li>
</ul>


The passage of the Sabka Bima Sabki Raksha (Amendment of Insurance Laws) Bill, 2025 marks a significant regulatory inflection point for the sector and could uplift penetration levels in long-run.
Key reforms include 100% FDI, easing operational constraints, strengthening consumer protection, opening up of Life Insurance of India (LICI IN) , etc. 
Tighter commission regulation and increased competition may pressure intermediary profitability in the near term, posing earnings risk for platforms like Policybazaar (POLICYBZ IN) (PB Fintech) despite positive long-term sector fundamentals.


New Insurance Bill: Insurance for All by 2047